IVF Success Rates in India: Complete 2026 Data Guide
Medically reviewed, data-driven breakdown of IVF success rates by age group, treatment type, and clinic tier — including India vs. abroad comparisons and transparent methodology notes. No clinic affiliations, no misleading statistics.
Understanding Success Rate Statistics
Success rates are population averages — they describe groups, not individuals. Your personal probability depends on age, diagnosis, embryo quality, and clinic expertise. Use these figures for informed comparison, not personal prediction. Always discuss your individual prognosis with your REI specialist.
Success Rates by Age
Age is the single most significant predictor of IVF success. As women age, egg quantity and quality decline, directly impacting fertilization rates, embryo development, and live birth outcomes. The data below reflects live birth rates per IVF cycle started, compiled from ICMR national registry data and ISAR clinical surveys for Indian patients.
Under 35
Clinical pregnancy: 55–60% · Miscarriage: 10–12%
Highest Rate
Ages 35–37
Clinical pregnancy: 44–50% · Miscarriage: 14–16%
Good
Ages 38–40
Clinical pregnancy: 32–38% · Miscarriage: 20–24%
Moderate
Ages 41–42
Clinical pregnancy: 20–26% · Miscarriage: 30–35%
Lower
Ages 43–44
Clinical pregnancy: 10–14% · Miscarriage: 40–50%
Significantly Lower
Any Age (Donor Egg)
Clinical pregnancy: 65–70% · Miscarriage: 8–10%
Consistent
Live Birth Rate vs. Clinical Pregnancy Rate
Clinics often quote "pregnancy rates" which include biochemical pregnancies and early losses. Always ask for live birth rates per cycle started — this is the only metric that reflects a baby taken home. Live birth rates are typically 10–15% lower than clinical pregnancy rates.
Success by Treatment
Different fertility treatments have significantly different success rates. The table below compares live birth rates per cycle across common ART procedures for women under 38, based on ICMR and SART data.
Live Birth Rates by Treatment Type (Women Under 38) · Source: ICMR National ART Registry 2024, SART 2023
| Treatment | Live birth rate | Clinical pregnancy | Cycles to success |
|---|---|---|---|
| IVF + ICSI (Fresh Transfer) — Standard cycle, own eggs | 40–45% | 55–60% | 2–3 |
| FET (Frozen Embryo Transfer) — Thawed embryo cycle | 38–44% | 52–58% | 2–3 |
| IVF + PGT-A (Euploid Transfer) — Genetically screened embryo | 55–65% | 65–72% | 1–2 |
| Donor Egg IVF — Third-party donor oocytes | 50–60% | 65–70% | 1–2 |
| IUI (Intrauterine Insemination) — Less invasive, first-line treatment | 10–18% | 15–22% | 3–6 |
| Ovulation Induction (OI) — Medication-only, timed intercourse | 8–12% | 12–18% | 4–6 |
* Live birth rates per cycle started for women under 38 using own eggs unless specified. Source: National ART & Surrogacy Registry of India; SART National Summary Report 2023.
Why PGT-A Shows Higher Rates
PGT-A screens embryos for chromosomal normality before transfer. Only euploid (chromosomally normal) embryos are transferred, which explains the higher per-transfer success rate. However, not all patients produce euploid embryos, and the added cost (₹60K–₹1.2L) must be weighed against individual benefit, particularly for women under 35.
India vs Abroad
Many Indian couples consider travelling abroad for IVF, particularly to countries like the USA, UK, or Spain. While international clinics may report higher headline rates, direct comparisons require careful interpretation — patient selection, reporting standards, and regulatory frameworks differ significantly.
IVF Live Birth Rate Comparison: India vs. International Destinations · Source: ICMR 2024, ESHRE 2023, SART 2023, HFEA 2023
| Country | Under 35 | 35–37 | 38–40 | Over 40 | Cost |
|---|---|---|---|---|---|
| 🇮🇳 India (Recommended Base) | 40–45% | 32–38% | 22–28% | 12–18% | ₹2–4L |
| 🇺🇸 USA (SART-reported data) | 45–50% | 38–44% | 26–32% | 14–20% | ₹18–25L |
| 🇬🇧 United Kingdom (HFEA-reported data) | 32–38% | 28–34% | 20–26% | 10–15% | ₹12–18L |
| 🇪🇸 Spain (SEF national registry) | 42–48% | 36–42% | 24–30% | 12–18% | ₹8–14L |
| 🇹🇭 Thailand (Regional IVF hub) | 38–44% | 30–36% | 20–26% | 10–16% | ₹5–9L |
Why India Compares Favorably
Success rates within 5–8% of top international clinics
Cost is 5–8x lower than USA, 3–5x lower than UK
Top Indian clinics accredited by NABH and ISAR
No travel, language, or cultural barriers
Better follow-up care continuity
Cautions When Comparing Rates
International clinics often treat younger, healthier patients (selection bias)
Reporting standards vary — not all report live birth rates
Travel adds stress, cost, and logistical complexity
Legal and ethical frameworks differ for donor cycles
Indian ART Act 2021 provides strong patient protections
What Impacts Your Odds
Beyond age, several clinical and lifestyle factors significantly influence IVF outcomes. Understanding these helps set realistic expectations and identify areas where intervention may improve your chances.
AMH Level (Ovarian Reserve)
AMH (Anti-Müllerian Hormone) predicts the number of eggs available for stimulation. Higher AMH generally means more eggs retrieved, more embryos, and more chances. Low AMH doesn't preclude success but may require protocol adjustments.
Embryo Quality & Grade
Blastocyst (Day 5) embryo quality is the strongest predictor of implantation success. Top-grade blastocysts (AA or AB by Gardner grading) have significantly higher implantation rates than cleavage-stage embryos.
Uterine Receptivity
Endometrial lining thickness (ideally 8–12mm), polyps, fibroids, adenomyosis, and uterine shape all affect implantation. ERA (Endometrial Receptivity Analysis) testing can identify the optimal transfer window for repeated implantation failures.
Sperm Quality & DNA Fragmentation
Sperm DNA fragmentation index (DFI) above 25% is associated with lower fertilization rates and higher miscarriage risk. ICSI with IMSI or PICSI selection can help in cases of high DFI. Male factor infertility affects ~40% of Indian couples.
BMI & Metabolic Health
BMI above 30 is associated with lower IVF success rates, higher miscarriage risk, and reduced ovarian response. Even a 5–10% weight reduction in overweight women can meaningfully improve outcomes before starting IVF.
Underlying Diagnosis
PCOS patients often have excellent egg response but face OHSS risk. Endometriosis can reduce egg quality. Unexplained infertility generally has good IVF outcomes. Premature ovarian insufficiency (POI) requires donor eggs for realistic success.
Number of Prior IVF Cycles
Cumulative success rates across multiple cycles are significantly higher than single-cycle rates. After 3 complete cycles with good-quality embryos, cumulative live birth rates for women under 38 can reach 70–80%. Protocol adjustments between cycles are critical.
Clinic & Lab Quality
Embryology lab quality, culture media, incubator technology, and time-lapse monitoring significantly affect embryo development rates. NABH-accredited and ISO-certified labs demonstrate higher consistency. Lab quality can account for 5–10% variation in outcomes between clinics.
Our Commitment to Data Integrity
ferti.health reports success rates using live birth rates per cycle started — the most conservative and meaningful metric for patients. We do not accept clinic-sponsored data or allow clinics to influence our reporting.
Metric Used
Live birth rate per cycle started (most conservative, most meaningful)
Data Sources
ICMR National ART Registry, ISAR surveys, SART, ESHRE, HFEA
Update Frequency
Annual data refresh aligned with ICMR registry release cycle
Live Birth Rate per Cycle Started
The most meaningful metric. Counts all cycles that began stimulation in the denominator — including those that were cancelled, had no eggs retrieved, or failed to fertilize. This gives the most honest picture of what patients actually experience.
Clinical Pregnancy Rate per Transfer
Counts only cycles that reached the transfer stage in the denominator. This is a more optimistic metric and is often quoted by clinics. It excludes cancelled cycles and failed fertilizations, making it 10–20% higher than live birth rates.
Positive Pregnancy Test Rate
The most optimistic and least meaningful metric. Includes biochemical pregnancies (positive test but no fetal heartbeat) and early losses. Often 20–30% higher than live birth rates. Be cautious of clinics that quote this figure without clarification.
Why We Don't Rank Individual Clinics
Individual clinic rankings can be misleading — clinics that treat older or more complex patients will naturally show lower rates. We provide tier-based benchmarks based on ICMR registry data to help you ask the right questions when evaluating clinics.
IVF Success Rate Benchmarks by Clinic Tier in India (Women Under 38, Own Eggs) · Source: ICMR ART Registry 2024
| Clinic tier | Live birth rate | Blastocyst rate | Cancellation rate | Annual cycles | Accreditation |
|---|---|---|---|---|---|
| Tier 1 — Super-Specialty — Mumbai, Delhi, Bengaluru premium centres | 42–50% | 55–65% | 8–12% | 500+ | NABH + ISAR |
| Tier 2 — Accredited IVF Centres — Major metro and Tier-1 city clinics | 35–42% | 45–55% | 12–18% | 200–500 | ISAR Certified |
| Tier 3 — Mid-Tier Private — Tier-2 cities, independent clinics | 25–35% | 35–45% | 18–25% | 100–200 | State Registered |
| Tier 4 — Government / Budget — Government hospitals, Tier-3 cities | 15–25% | 25–35% | 25–35% | <100 | MoHFW Registered |
Questions to Ask Your Clinic About Success Rates
What is your live birth rate per cycle started for my age group?
What is your blastocyst development rate and embryo freezing rate?
How many IVF cycles does your lab perform per year?
What is your cycle cancellation rate due to poor response?
Is your data submitted to the ICMR ART National Registry?
Can you provide data specifically for patients with my diagnosis?
References & Citations
- National ART & Surrogacy Registry of India (DHR/ICMR, MoHFW). National registry of ART clinics and outcomes. ICMR Registry
- Society for Assisted Reproductive Technology (SART). National Summary Report 2023. Birmingham, AL: SART. sartcorsonline.com
- European Society of Human Reproduction and Embryology (ESHRE). European IVF Monitoring (EIM) Consortium — ART data collection. eshre.eu/eim
- Human Fertilisation and Embryology Authority (HFEA). Fertility Treatment 2023: Trends and Figures. London: HFEA, 2025. hfea.gov.uk
- Indian Society for Assisted Reproduction (ISAR). Professional society resources on assisted reproduction in India. ISAR
- McLernon DJ, et al. Cumulative live birth rates after one or more complete cycles of IVF: a population-based study of linked cycle and pregnancy data. Hum Reprod / BMJ. 2016. PubMed PMID: 26783243. PubMed
Medical Disclaimer: This guide is for educational purposes only and does not constitute medical advice. Always consult a qualified reproductive endocrinologist for diagnosis and treatment recommendations specific to your situation.